{
    "status": "ok",
    "totalResults": 96,
    "articles": [
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research Nester",
            "title": "Blood Screening Market revenue to hit USD 5.03 Billion by 2035, says Research Nester",
            "description": "Key blood screening market players include Abbott Laboratories, Grifols, S.A., Quotient Limited, Thermo Fisher Scientific Inc., BD, Ortho al Diagnostics, DiaSorin S.p.A., Bio-Rad Laboratories, Inc., Danaher Corporation, Beckman Coulter, Inc., and others. Key \u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/28/2786755/0/en/Blood-Screening-Market-revenue-to-hit-USD-5-03-Billion-by-2035-says-Research-Nester.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/77e335b1-e272-4a4c-a0ff-211ce0caee29",
            "publishedAt": "2023-11-28T11:00:00Z",
            "content": "New York, Nov. 28, 2023 (GLOBE NEWSWIRE) -- The global blood screening market size is poised to grow at a CAGR of over 6% from 2023 to 2035. The market is anticipated to garner a revenue of USD 5.3 b\u2026 [+6053 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research Nester",
            "title": "Lateral Flow Assays Market revenue to exceed USD 180 Billion by 2035, says Research Nester",
            "description": "Major lateral flow assays (LFA) market players include Abbott Laboratories, Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc., Danaher Corporation, F.Hoffmann-La Roche AG, QIAGEN N.V., Siemens Healthineers AG, Thermo Fisher Scientific, Inc., Merck kG\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/08/2775915/0/en/Lateral-Flow-Assays-Market-revenue-to-exceed-USD-180-Billion-by-2035-says-Research-Nester.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/77e335b1-e272-4a4c-a0ff-211ce0caee29",
            "publishedAt": "2023-11-08T10:00:00Z",
            "content": "New York, Nov. 08, 2023 (GLOBE NEWSWIRE) -- The global lateral flow assays market size is expected to expand at ~7% CAGR from 2023 to 2035. The market is anticipated to garner a revenue of USD 180 bi\u2026 [+5964 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Westpac Banking Corp Reduces Stock Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)",
            "description": "Westpac Banking Corp lowered its position in Bio-Rad Laboratories, Inc. (NYSE:BIO \u2013 Free Report) by 54.0% in the second quarter, HoldingsChannel reports. The institutional investor owned 3,796 shares of the medical research company\u2019s stock after selling 4,459\u2026",
            "url": "https://www.etfdailynews.com/2023/11/17/westpac-banking-corp-reduces-stock-holdings-in-bio-rad-laboratories-inc-nysebio/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/bio-rad-laboratories-inc-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-17T17:56:42Z",
            "content": "Westpac Banking Corp lowered its position in Bio-Rad Laboratories, Inc. (NYSE:BIO \u2013 Free Report) by 54.0% in the second quarter, HoldingsChannel reports. The institutional investor owned 3,796 shares\u2026 [+5923 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Champlain Investment Partners LLC Has $97.33 Million Stake in Bio-Rad Laboratories, Inc. (NYSE:BIO)",
            "description": "Champlain Investment Partners LLC grew its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO \u2013 Free Report) by 17.9% in the 2nd quarter, Holdings Channel.com reports. The fund owned 256,730 shares of the medical research company\u2019s stock after purchasing an additi\u2026",
            "url": "https://www.etfdailynews.com/2023/11/28/champlain-investment-partners-llc-has-97-33-million-stake-in-bio-rad-laboratories-inc-nysebio/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/bio-rad-laboratories-inc-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-28T18:34:47Z",
            "content": "Champlain Investment Partners LLC grew its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO \u2013 Free Report) by 17.9% in the 2nd quarter, Holdings Channel.com reports. The fund owned 256,730 shares of the\u2026 [+5407 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Element Capital Management LLC Purchases 151 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)",
            "description": "Element Capital Management LLC grew its position in Bio-Rad Laboratories, Inc. (NYSE:BIO \u2013 Free Report) by 5.8% in the second quarter, Holdings Channel reports. The fund owned 2,771 shares of the medical research company\u2019s stock after acquiring an additional \u2026",
            "url": "https://www.etfdailynews.com/2023/11/24/element-capital-management-llc-purchases-151-shares-of-bio-rad-laboratories-inc-nysebio/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/bio-rad-laboratories-inc-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-24T14:03:05Z",
            "content": "Element Capital Management LLC grew its position in Bio-Rad Laboratories, Inc. (NYSE:BIO \u2013 Free Report) by 5.8% in the second quarter, Holdings Channel reports. The fund owned 2,771 shares of the med\u2026 [+5513 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "InsightAce Analytic Pvt. LTd.",
            "title": "DNA/RNA Sample Extraction and Isolation Market Detailed Analysis Report 2023-2031",
            "description": "Companies covered in this report are Abnova Corporation, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, Illumina, Inc., MACHEREY-NAGEL GmbH & Co. KG, Merck KGaA, Norgen Biotek Corp., Omega Bio-tek, Inc., Promega Corporation,\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/16/2781567/0/en/DNA-RNA-Sample-Extraction-and-Isolation-Market-Detailed-Analysis-Report-2023-2031.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/0e88e2e9-67b2-4a38-aa13-e33c9d874fc5",
            "publishedAt": "2023-11-16T07:34:00Z",
            "content": "Jersey City, NJ, Nov. 16, 2023 (GLOBE NEWSWIRE) -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the \"Global DNA/RNA Sample Extraction and Isolation Market- (By\u2026 [+9384 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Meritage Group LP Makes New Investment in Bio-Rad Laboratories, Inc. (NYSE:BIO)",
            "description": "Meritage Group LP purchased a new stake in Bio-Rad Laboratories, Inc. (NYSE:BIO \u2013 Free Report) in the second quarter, HoldingsChannel reports. The institutional investor purchased 753 shares of the medical research company\u2019s stock, valued at approximately $28\u2026",
            "url": "https://www.etfdailynews.com/2023/11/27/meritage-group-lp-makes-new-investment-in-bio-rad-laboratories-inc-nysebio/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/bio-rad-laboratories-inc-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-27T17:56:44Z",
            "content": "Meritage Group LP purchased a new stake in Bio-Rad Laboratories, Inc. (NYSE:BIO \u2013 Free Report) in the second quarter, HoldingsChannel reports. The institutional investor purchased 753 shares of the m\u2026 [+5809 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Tamarack Advisers LP Boosts Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)",
            "description": "Tamarack Advisers LP grew its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO \u2013 Free Report) by 100.0% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,000 shares of the medical r\u2026",
            "url": "https://www.etfdailynews.com/2023/11/15/tamarack-advisers-lp-boosts-position-in-bio-rad-laboratories-inc-nysebio/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/bio-rad-laboratories-inc-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-15T14:50:55Z",
            "content": "Tamarack Advisers LP grew its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO \u2013 Free Report) by 100.0% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Co\u2026 [+6592 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "InsightAce Analytic Pvt. LTd.",
            "title": "Baculovirus Expression System Market Latest Report with Forecast to 2031",
            "description": "Companies covered in this report are Thermo Fisher Scientific, Merck KGaA, Takara Bio, Agilent Technologies, Oxford Expression Technologies, Promega Corporation, Qiagen N.V., Bio-Rad Laboratories, New England Biolabs, Genscript Biotech Corporation, Syngene In\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/27/2785973/0/en/Baculovirus-Expression-System-Market-Latest-Report-with-Forecast-to-2031.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/0e88e2e9-67b2-4a38-aa13-e33c9d874fc5",
            "publishedAt": "2023-11-27T11:10:00Z",
            "content": "Jersey City, NJ,, Nov. 27, 2023 (GLOBE NEWSWIRE) -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the \"Global Baculovirus Expression System Market- (By Product \u2026 [+8466 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Gamco Investors INC. ET AL Sells 85 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)",
            "description": "Gamco Investors INC. ET AL decreased its position in Bio-Rad Laboratories, Inc. (NYSE:BIO \u2013 Free Report) by 0.3% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional inves\u2026",
            "url": "https://www.etfdailynews.com/2023/11/21/gamco-investors-inc-et-al-sells-85-shares-of-bio-rad-laboratories-inc-nysebio/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/bio-rad-laboratories-inc-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-21T15:04:49Z",
            "content": "Gamco Investors INC. ET AL decreased its position in Bio-Rad Laboratories, Inc. (NYSE:BIO \u2013 Free Report) by 0.3% in the second quarter, according to the company in its most recent disclosure with the\u2026 [+6354 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "SPHERICAL INSIGHTS LLP",
            "title": "Global Molecular Quality Controls Market Size To Worth USD 367.24 Million By 2032 | CAGR of 6.5%",
            "description": "The Molecular Quality Controls Market was valued at USD 195.64 Million in 2022. The Global molecular quality controls market is expected to reach USD 367.24 Million by 2032, According to a research report published by Spherical Insights & Consulting. Companie\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/12/01/2789085/0/en/Global-Molecular-Quality-Controls-Market-Size-To-Worth-USD-367-24-Million-By-2032-CAGR-of-6-5.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/b27a94e8-407e-46ae-a5c2-47bb2a1c8a2e",
            "publishedAt": "2023-12-01T07:00:00Z",
            "content": "New York, United States , Dec. 01, 2023 (GLOBE NEWSWIRE) -- The Global Molecular Quality Controls Market size is to grow from USD 195.64 Million in 2022 to USD 367.24 Million by 2032, at a Compound A\u2026 [+10979 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Hsbc Holdings PLC Sells 3,094 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)",
            "description": "Hsbc Holdings PLC cut its position in Bio-Rad Laboratories, Inc. (NYSE:BIO \u2013 Free Report) by 16.2% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 16,054 shares of the medical resear\u2026",
            "url": "https://www.etfdailynews.com/2023/12/02/hsbc-holdings-plc-sells-3094-shares-of-bio-rad-laboratories-inc-nysebio/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/bio-rad-laboratories-inc-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-12-02T13:52:50Z",
            "content": "Hsbc Holdings PLC cut its position in Bio-Rad Laboratories, Inc. (NYSE:BIO \u2013 Free Report) by 16.2% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Co\u2026 [+5717 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Bio-Rad Laboratories, Inc. (NYSE:BIO) Shares Bought by Gabelli Funds LLC",
            "description": "Gabelli Funds LLC raised its position in Bio-Rad Laboratories, Inc. (NYSE:BIO \u2013 Free Report) by 1.4% during the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 37,200 shares of the medical research company\u2019s stock after purch\u2026",
            "url": "https://www.etfdailynews.com/2023/11/21/bio-rad-laboratories-inc-nysebio-shares-bought-by-gabelli-funds-llc/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/bio-rad-laboratories-inc-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-21T14:20:41Z",
            "content": "Gabelli Funds LLC raised its position in Bio-Rad Laboratories, Inc. (NYSE:BIO \u2013 Free Report) by 1.4% during the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 37,20\u2026 [+5936 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Beverly Hills Private Wealth LLC Buys 946 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)",
            "description": "Beverly Hills Private Wealth LLC lifted its position in Bio-Rad Laboratories, Inc. (NYSE:BIO \u2013 Free Report) by 108.4% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,819 sh\u2026",
            "url": "https://www.etfdailynews.com/2023/11/16/beverly-hills-private-wealth-llc-buys-946-shares-of-bio-rad-laboratories-inc-nysebio/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/bio-rad-laboratories-inc-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-16T15:24:48Z",
            "content": "Beverly Hills Private Wealth LLC lifted its position in Bio-Rad Laboratories, Inc. (NYSE:BIO \u2013 Free Report) by 108.4% during the second quarter, according to its most recent 13F filing with the Secur\u2026 [+6120 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "SPHERICAL INSIGHTS LLP",
            "title": "Global Blood Group Typing Market Size To Worth USD 3.98 Billion by 2032 | CAGR of 8.4%",
            "description": "The Global Blood Group Typing Market Size was valued at USD 1.78 Billion in 2022. The Worldwide Blood Group Typing Market Size is expected to reach USD 3.98 Billion by 2032, According to a research report published by Spherical Insights & Consulting. Companie\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/12/04/2789811/0/en/Global-Blood-Group-Typing-Market-Size-To-Worth-USD-3-98-Billion-by-2032-CAGR-of-8-4.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/b27a94e8-407e-46ae-a5c2-47bb2a1c8a2e",
            "publishedAt": "2023-12-04T10:45:00Z",
            "content": "New York, United States , Dec. 04, 2023 (GLOBE NEWSWIRE) -- The Global Blood Group Typing Market Size is to Grow from USD 1.78 Billion in 2022 to USD 3.98 Billion by 2032, at a Compound Annual Growth\u2026 [+10044 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Huntington National Bank Sells 69 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)",
            "description": "Huntington National Bank trimmed its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO \u2013 Free Report) by 31.8% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm\u2026",
            "url": "https://www.etfdailynews.com/2023/11/30/huntington-national-bank-sells-69-shares-of-bio-rad-laboratories-inc-nysebio/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/bio-rad-laboratories-inc-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-30T13:50:46Z",
            "content": "Huntington National Bank trimmed its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO \u2013 Free Report) by 31.8% in the second quarter, according to the company in its most recent Form 13F filing\u2026 [+5083 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Bridgewater Associates LP Raises Stake in Bio-Rad Laboratories, Inc. (NYSE:BIO)",
            "description": "Bridgewater Associates LP increased its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO \u2013 Free Report) by 1,950.9% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 16,469 \u2026",
            "url": "https://www.etfdailynews.com/2023/11/27/bridgewater-associates-lp-raises-stake-in-bio-rad-laboratories-inc-nysebio/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/bio-rad-laboratories-inc-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-27T15:34:48Z",
            "content": "Bridgewater Associates LP increased its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO \u2013 Free Report) by 1,950.9% in the second quarter, according to its most recent 13F filing with the Securities &am\u2026 [+5823 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Portolan Capital Management LLC Grows Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)",
            "description": "Portolan Capital Management LLC grew its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO \u2013 Free Report) by 19.6% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The\u2026",
            "url": "https://www.etfdailynews.com/2023/12/04/portolan-capital-management-llc-grows-holdings-in-bio-rad-laboratories-inc-nysebio/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/bio-rad-laboratories-inc-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-12-04T16:50:49Z",
            "content": "Portolan Capital Management LLC grew its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO \u2013 Free Report) by 19.6% during the 2nd quarter, according to the company in its most recent Form 13F f\u2026 [+5410 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Canada Pension Plan Investment Board Cuts Stock Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)",
            "description": "Canada Pension Plan Investment Board lessened its position in Bio-Rad Laboratories, Inc. (NYSE:BIO \u2013 Free Report) by 0.9% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 68,467 shares of \u2026",
            "url": "https://www.etfdailynews.com/2023/11/15/canada-pension-plan-investment-board-cuts-stock-position-in-bio-rad-laboratories-inc-nysebio/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/bio-rad-laboratories-inc-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-15T14:02:43Z",
            "content": "Canada Pension Plan Investment Board lessened its position in Bio-Rad Laboratories, Inc. (NYSE:BIO \u2013 Free Report) by 0.9% during the 2nd quarter, according to its most recent filing with the Securiti\u2026 [+5988 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Polar Capital Holdings Plc Reduces Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)",
            "description": "Polar Capital Holdings Plc cut its position in Bio-Rad Laboratories, Inc. (NYSE:BIO \u2013 Free Report) by 83.3% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 24,751 sh\u2026",
            "url": "https://www.etfdailynews.com/2023/12/04/polar-capital-holdings-plc-reduces-position-in-bio-rad-laboratories-inc-nysebio/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/bio-rad-laboratories-inc-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-12-04T14:42:43Z",
            "content": "Polar Capital Holdings Plc cut its position in Bio-Rad Laboratories, Inc. (NYSE:BIO \u2013 Free Report) by 83.3% during the second quarter, according to the company in its most recent 13F filing with the \u2026 [+4542 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Insider Selling: Bio-Rad Laboratories, Inc. (NYSE:BIO) EVP Sells $195,874.20 in Stock",
            "description": "Bio-Rad Laboratories, Inc. (NYSE:BIO \u2013 Get Free Report) EVP Michael Crowley sold 642 shares of the company\u2019s stock in a transaction that occurred on Tuesday, November 28th. The stock was sold at an average price of $305.10, for a total value of $195,874.20. F\u2026",
            "url": "https://www.etfdailynews.com/2023/12/01/insider-selling-bio-rad-laboratories-inc-nysebio-evp-sells-195874-20-in-stock/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/bio-rad-laboratories-inc-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-12-01T10:24:41Z",
            "content": "Bio-Rad Laboratories, Inc. (NYSE:BIO \u2013 Get Free Report) EVP Michael Crowley sold 642 shares of the company\u2019s stock in a transaction that occurred on Tuesday, November 28th. The stock was sold at an a\u2026 [+4576 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Brandywine Global Investment Management LLC Sells 1,703 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)",
            "description": "Brandywine Global Investment Management LLC lowered its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO \u2013 Free Report) by 10.8% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 14,04\u2026",
            "url": "https://www.etfdailynews.com/2023/11/28/brandywine-global-investment-management-llc-sells-1703-shares-of-bio-rad-laboratories-inc-nysebio/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/bio-rad-laboratories-inc-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-28T15:20:49Z",
            "content": "Brandywine Global Investment Management LLC lowered its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO \u2013 Free Report) by 10.8% in the second quarter, according to its most recent Form 13F filing with \u2026 [+5608 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Bio-Rad Laboratories, Inc. (NYSE:BIO) Stock Position Lowered by New York Life Investment Management LLC",
            "description": "New York Life Investment Management LLC reduced its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO \u2013 Free Report) by 4.8% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commiss\u2026",
            "url": "https://www.etfdailynews.com/2023/11/07/bio-rad-laboratories-inc-nysebio-stock-position-lowered-by-new-york-life-investment-management-llc/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/bio-rad-laboratories-inc-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-07T13:18:42Z",
            "content": "New York Life Investment Management LLC reduced its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO \u2013 Free Report) by 4.8% during the second quarter, according to the company in its most r\u2026 [+6420 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "WFA of San Diego LLC Has $474,000 Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)",
            "description": "WFA of San Diego LLC lowered its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO \u2013 Free Report) by 3.8% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,250 sh\u2026",
            "url": "https://www.etfdailynews.com/2023/11/20/wfa-of-san-diego-llc-has-474000-position-in-bio-rad-laboratories-inc-nysebio/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/bio-rad-laboratories-inc-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-20T15:18:58Z",
            "content": "WFA of San Diego LLC lowered its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO \u2013 Free Report) by 3.8% in the second quarter, according to the company in its most recent disclosure with t\u2026 [+6691 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Acadian Asset Management LLC Sells 125,578 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)",
            "description": "Acadian Asset Management LLC decreased its position in Bio-Rad Laboratories, Inc. (NYSE:BIO \u2013 Free Report) by 50.5% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional\u2026",
            "url": "https://www.etfdailynews.com/2023/11/06/acadian-asset-management-llc-sells-125578-shares-of-bio-rad-laboratories-inc-nysebio/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/bio-rad-laboratories-inc-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-06T14:28:41Z",
            "content": "Acadian Asset Management LLC decreased its position in Bio-Rad Laboratories, Inc. (NYSE:BIO \u2013 Free Report) by 50.5% in the 2nd quarter, according to the company in its most recent 13F filing with the\u2026 [+6447 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Acadian Asset Management LLC Cuts Stake in Bio-Rad Laboratories, Inc. (NYSE:BIO)",
            "description": "Acadian Asset Management LLC lessened its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO \u2013 Free Report) by 50.5% in the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 122,958 shares of the medical research c\u2026",
            "url": "https://www.etfdailynews.com/2023/11/06/acadian-asset-management-llc-cuts-stake-in-bio-rad-laboratories-inc-nysebio/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/bio-rad-laboratories-inc-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-06T14:28:41Z",
            "content": "Acadian Asset Management LLC lessened its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO \u2013 Free Report) by 50.5% in the second quarter, according to its most recent Form 13F filing with the \u2026 [+6302 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Earnest Partners LLC Has $106.13 Million Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)",
            "description": "Earnest Partners LLC grew its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO \u2013 Free Report) by 10.4% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 279,940 shares of the medical research company\u2019s\u2026",
            "url": "https://www.etfdailynews.com/2023/11/05/earnest-partners-llc-has-106-13-million-position-in-bio-rad-laboratories-inc-nysebio/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/bio-rad-laboratories-inc-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-05T16:40:50Z",
            "content": "Earnest Partners LLC grew its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO \u2013 Free Report) by 10.4% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The\u2026 [+6611 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Acadian Asset Management LLC Trims Stock Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)",
            "description": "Acadian Asset Management LLC trimmed its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO \u2013 Free Report) by 50.5% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 122,958 shares \u2026",
            "url": "https://www.etfdailynews.com/2023/11/06/acadian-asset-management-llc-trims-stock-position-in-bio-rad-laboratories-inc-nysebio/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/bio-rad-laboratories-inc-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-06T14:28:41Z",
            "content": "Acadian Asset Management LLC trimmed its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO \u2013 Free Report) by 50.5% during the second quarter, according to its most recent 13F filing with the Securities a\u2026 [+6277 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "SPHERICAL INSIGHTS LLP",
            "title": "Global Infectious Disease Diagnostics Market Size To Worth USD 38.02 Billion By 2032 | CAGR of 5.4%",
            "description": "The Global Infectious Disease Diagnostics Market Size was valued at USD 22.47 Billion in 2022 and the Worldwide Infectious Disease Diagnostics Market Size is expected to reach USD 38.02 Billion by 2032, according to a research report published by Spherical In\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/28/2787090/0/en/Global-Infectious-Disease-Diagnostics-Market-Size-To-Worth-USD-38-02-Billion-By-2032-CAGR-of-5-4.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/b27a94e8-407e-46ae-a5c2-47bb2a1c8a2e",
            "publishedAt": "2023-11-28T14:30:00Z",
            "content": "New York, United States, Nov. 28, 2023 (GLOBE NEWSWIRE) -- The Global Infectious Disease Diagnostics Market Size is to Grow from USD 22.47 Billion in 2022 to USD 38.02 Billion by 2032, at a Compound \u2026 [+11647 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "SPHERICAL INSIGHTS LLP",
            "title": "Global Cloning & Mutagenesis Market Size To Worth USD 12.45 Billion by 2032 | CAGR of 18.7%",
            "description": "The Global Cloning & Mutagenesis Market Size is anticipated to exceed USD 12.45 Billion by 2032, growing at a CAGR of 18.7% from 2022 to 2032, According to a research report published by Spherical Insights & Consulting. Agilent Technologies, Inc., Thermo Fish\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/22/2784557/0/en/Global-Cloning-Mutagenesis-Market-Size-To-Worth-USD-12-45-Billion-by-2032-CAGR-of-18-7.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/b27a94e8-407e-46ae-a5c2-47bb2a1c8a2e",
            "publishedAt": "2023-11-22T07:00:00Z",
            "content": "New York, United States , Nov. 22, 2023 (GLOBE NEWSWIRE) -- The\u00a0Global Cloning &amp; Mutagenesis Market\u00a0Size is to grow from USD 2.24 Billion in 2022 to USD 12.45 Billion by 2032, at a Compound Annua\u2026 [+10456 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "SPHERICAL INSIGHTS LLP",
            "title": "Global Immunoassay Market Size To Worth USD 53.87 Billion By 2032 | CAGR of 5.2%",
            "description": "The Global Immunoassay Market Size was valued at USD 32.45 Billion in 2022 and the Global immunoassay market Size is expected to reach USD 53.87 Billion by 2032, according to a research report published by Spherical Insights & Consulting. Companies Covered: S\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/17/2782435/0/en/Global-Immunoassay-Market-Size-To-Worth-USD-53-87-Billion-By-2032-CAGR-of-5-2.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/b27a94e8-407e-46ae-a5c2-47bb2a1c8a2e",
            "publishedAt": "2023-11-17T10:00:00Z",
            "content": "New York, United States, Nov. 17, 2023 (GLOBE NEWSWIRE) -- The Global Immunoassay Market Size is to grow from USD 32.45 Billion in 2022 to USD 53.87 Billion by 2032, at a Compound Annual Growth Rate \u2026 [+11204 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Polaris Market Research & Consulting LLP",
            "title": "Global Protein A Resin Market Share Projected to be Worth USD 2,854.41 Million By 2032, at 9.4% CAGR Increase: Polaris Market Research",
            "description": "Global protein A resin market size & share is currently valued at USD 1,168.78 Million in 2022 and is anticipated to generate an estimated revenue of USD 2,854.41 Million by 2032, according to the latest study by Polaris Market Research. Besides, the report n\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/20/2783158/0/en/Global-Protein-A-Resin-Market-Share-Projected-to-be-Worth-USD-2-854-41-Million-By-2032-at-9-4-CAGR-Increase-Polaris-Market-Research.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/cf0a808d-3703-43f4-9b34-ec72345f8585",
            "publishedAt": "2023-11-20T12:50:00Z",
            "content": "New York, NY, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Polaris Market Research has published a recent study report titled \"Protein A Resin Market Share, Size, Trends, Industry Analysis Report, By Type (Reco\u2026 [+13667 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "InsightAce Analytic Pvt. LTd.",
            "title": "Cell and Gene Therapy Bio-manufacturing Market | Current Trends and Future Scope Analysis 2023-2031",
            "description": "Companies covered in this report are Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Danaher Corporation, Endress+Hauser Group Services AG (Analytik Jena GmbH), General Electric Company (G.E. Healthcare), Getinge AB, Infors \u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/16/2781604/0/en/Cell-and-Gene-Therapy-Bio-manufacturing-Market-Current-Trends-and-Future-Scope-Analysis-2023-2031.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/0e88e2e9-67b2-4a38-aa13-e33c9d874fc5",
            "publishedAt": "2023-11-16T09:27:00Z",
            "content": "Jersey City, NJ, Nov. 16, 2023 (GLOBE NEWSWIRE) -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the \"Global\u00a0Cell and Gene Therapy Bio-manufacturing Market Size\u2026 [+8987 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "SPHERICAL INSIGHTS LLP",
            "title": "Global Legionella Testing Market Size To Worth USD 619.68 Million by 2032 | CAGR of 7.8%",
            "description": "The Global Legionella Testing Market Size was valued at USD 292.40 Million in 2022 and the Worldwide Legionella Testing Market Size is expected to reach USD 619.68 Million by 2032, according to a research report published by Spherical Insights & Consulting. C\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/23/2785206/0/en/Global-Legionella-Testing-Market-Size-To-Worth-USD-619-68-Million-by-2032-CAGR-of-7-8.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/b27a94e8-407e-46ae-a5c2-47bb2a1c8a2e",
            "publishedAt": "2023-11-23T11:00:00Z",
            "content": "New York, United States, Nov. 23, 2023 (GLOBE NEWSWIRE) -- The Global Legionella Testing Market Size is To Grow from USD 292.40 Million in 2022 to USD 619.68 Million by 2032, at a Compound Annual Gro\u2026 [+9763 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "SPHERICAL INSIGHTS LLP",
            "title": "Global Multiplex Assay Market Size To Grow USD 7.1 Billion By 2032 | CAGR of 7.3%",
            "description": "The Global Multiplex Assay Market Size was valued at USD 3.5 Billion in 2022 and the Worldwide Multiplex Assay Market size is expected to reach USD 7.1 Billion by 2032, according to a research report published by Spherical Insights & Consulting. Companies Cov\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/06/2773754/0/en/Global-Multiplex-Assay-Market-Size-To-Grow-USD-7-1-Billion-By-2032-CAGR-of-7-3.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/b27a94e8-407e-46ae-a5c2-47bb2a1c8a2e",
            "publishedAt": "2023-11-06T08:40:00Z",
            "content": "New York, United States, Nov. 06, 2023 (GLOBE NEWSWIRE) -- The Global Multiplex Assay Market Size is expected to reach USD 7.1 Billion by 2032, at a CAGR of 7.3% during the forecast period 2022 to 20\u2026 [+11377 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "SPHERICAL INSIGHTS LLP",
            "title": "Global Liquid Biopsy Market Size To Worth USD 25.24 Billion By 2032 | CAGR of 11.5%",
            "description": "The Liquid Biopsy Market Size was valued at USD 8.50 Billion in 2022 and the Worldwide liquid biopsy market Size is expected to reach USD 25.24 Billion By 2032, according to a research report published by Spherical Insights & Consulting. Companies Covered: Bi\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/15/2780820/0/en/Global-Liquid-Biopsy-Market-Size-To-Worth-USD-25-24-Billion-By-2032-CAGR-of-11-5.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/b27a94e8-407e-46ae-a5c2-47bb2a1c8a2e",
            "publishedAt": "2023-11-15T10:30:00Z",
            "content": "New York, United States, Nov. 15, 2023 (GLOBE NEWSWIRE) -- The Global Liquid Biopsy Market Size is expected to reach USD 25.24 Billion By 2032, at a CAGR of 11.5% during the forecast period 2022\u00a0to 2\u2026 [+11486 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "SPHERICAL INSIGHTS LLP",
            "title": "Global Point-of-Care Molecular Diagnostics Market Size To Worth USD 11.84 Billion By 2032 | CAGR of 5.2%",
            "description": "The Global Point-of-Care Molecular Diagnostics Market Size was valued at USD 7.13 Billion in 2022 and the Worldwide Point-of-Care Molecular Diagnostics Market Size is expected to reach USD 11.84 Billion by 2032, according to a research report published by Sph\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/06/2774150/0/en/Global-Point-of-Care-Molecular-Diagnostics-Market-Size-To-Worth-USD-11-84-Billion-By-2032-CAGR-of-5-2.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/b27a94e8-407e-46ae-a5c2-47bb2a1c8a2e",
            "publishedAt": "2023-11-06T13:50:00Z",
            "content": "New York, United States, Nov. 06, 2023 (GLOBE NEWSWIRE) -- The Global Point-of-Care Molecular Diagnostics Market Size is to Grow from USD 7.13 Billion in 2022 to USD 11.84 Billion by 2032, at a Compo\u2026 [+10369 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research and Markets",
            "title": "Blood Screening (Reagent & Kits, Instrument, Software) Market - Global Forecast to 2028 Featuring F. Hoffmann-La Roche, Grifols, Abbott Laboratories, Bio-Rad Laboratories, Danaher, and bioMerieux",
            "description": "Dublin, Nov. 10, 2023 (GLOBE NEWSWIRE) -- The \"Blood Screening Market by Product (Reagent & Kits, Instrument, Software), Technology (NAT, (Real-Time PCR), ELISA (Chemiluminescence Immunoassay), Rapid Test, Western Blot), End User (Blood Bank, Hospital), & Reg\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/10/2778132/28124/en/Blood-Screening-Reagent-Kits-Instrument-Software-Market-Global-Forecast-to-2028-Featuring-F-Hoffmann-La-Roche-Grifols-Abbott-Laboratories-Bio-Rad-Laboratories-Danaher-and-bioMerieu.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7",
            "publishedAt": "2023-11-10T10:13:00Z",
            "content": "Dublin, Nov. 10, 2023 (GLOBE NEWSWIRE) -- The \"Blood Screening Market by Product (Reagent &amp; Kits, Instrument, Software), Technology (NAT, (Real-Time PCR), ELISA (Chemiluminescence Immunoassay), R\u2026 [+6037 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "SPHERICAL INSIGHTS LLP",
            "title": "Global Biotechnology Instruments Market Size To Exceed USD 152.5 Billion by 2032 | CAGR of 8.1%",
            "description": "The Global Biotechnology Instruments Market Size was valued at USD 69.7 Billion in 2022 and the Worldwide Biotechnology Instruments Market Size is expected to reach USD 152.5 Billion by 2032, according to a research report published by Spherical Insights & Co\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/12/04/2790155/0/en/Global-Biotechnology-Instruments-Market-Size-To-Exceed-USD-152-5-Billion-by-2032-CAGR-of-8-1.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/b27a94e8-407e-46ae-a5c2-47bb2a1c8a2e",
            "publishedAt": "2023-12-04T15:00:00Z",
            "content": "New York, United States, Dec. 04, 2023 (GLOBE NEWSWIRE) -- The Global Biotechnology Instruments Market Size is to Grow from USD 69.7 Billion in 2022 to USD 152.5 Billion by 2032, at a Compound Annual\u2026 [+10248 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research and Markets",
            "title": "Laboratory Equipment Market Size & Trends Analysis Report 2023: A Global $50+ Billion Industry by 2030 Featuring Sartorius, Bio-Rad Labs, FUJIFILM, Thermo Fisher Scientific, Agilent Technologies",
            "description": "Dublin, Nov. 14, 2023 (GLOBE NEWSWIRE) -- The \"Laboratory Equipment Market Size, Share & Trends Analysis Report By Product (General, Analytical, Clinical, Support, Specialty), By End-use (Research Institutions, Healthcare, Veterinary), By Region, And Segment \u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/14/2779757/28124/en/Laboratory-Equipment-Market-Size-Trends-Analysis-Report-2023-A-Global-50-Billion-Industry-by-2030-Featuring-Sartorius-Bio-Rad-Labs-FUJIFILM-Thermo-Fisher-Scientific-Agilent-Technol.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7",
            "publishedAt": "2023-11-14T08:08:00Z",
            "content": "Dublin, Nov. 14, 2023 (GLOBE NEWSWIRE) -- The \"Laboratory Equipment Market Size, Share &amp; Trends Analysis Report By Product (General, Analytical, Clinical, Support, Specialty), By End-use (Researc\u2026 [+4252 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research and Markets",
            "title": "Key Players in India's Emerging Infectious Disease Diagnostics Market Drive Innovations in Disease Diagnosis, Collaborations, and CRISPR-Based Testing Solutions",
            "description": "Dublin, Nov. 09, 2023 (GLOBE NEWSWIRE) -- The \"India Emerging Infectious Disease Diagnostics Market: Focus on Epidemiology, Application, Technology, Type of Infection, Disease Type, and End User - Analysis and Forecast, 2023-2033\" report has been added to Res\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/09/2777244/28124/en/Key-Players-in-India-s-Emerging-Infectious-Disease-Diagnostics-Market-Drive-Innovations-in-Disease-Diagnosis-Collaborations-and-CRISPR-Based-Testing-Solutions.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7",
            "publishedAt": "2023-11-09T12:33:00Z",
            "content": "Dublin, Nov. 09, 2023 (GLOBE NEWSWIRE) -- The \"India Emerging Infectious Disease Diagnostics Market: Focus on Epidemiology, Application, Technology, Type of Infection, Disease Type, and End User - An\u2026 [+8299 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Transparency Market Research",
            "title": "Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Size & Share to Surpass USD 7.5 billion by 2031 | Analysis by Transparency Market Research",
            "description": "Growing emphasis on robust data analysis tools and software enhances the utility of dPCR and qPCR platforms, enabling efficient interpretation and utilization of complex molecular data. Growing emphasis on robust data analysis tools and software enhances the \u2026",
            "url": "https://www.globenewswire.com/news-release/2023/12/04/2790178/32656/en/Digital-PCR-dPCR-and-Quantitative-PCR-qPCR-Market-Size-Share-to-Surpass-USD-7-5-billion-by-2031-Analysis-by-Transparency-Market-Research.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/27b21b27-620b-4cae-8360-605a9662092b",
            "publishedAt": "2023-12-04T15:30:00Z",
            "content": "Wilmington, Delaware, United States, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global digital PCR (dPCR) and quantitative PCR (qPCR) market is estimated to flourish at\u2026 [+8468 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research and Markets",
            "title": "Global Protein Assays Market Report 2023: A $4.2 Billion Market by 2027 - Long-term Forecast to 2032",
            "description": "Dublin, Nov. 09, 2023 (GLOBE NEWSWIRE) -- The \"Protein Assays Global Market Report 2023\" report has been added to ResearchAndMarkets.com's offering.The global protein assays market is expected to grow from $2.22 billion in 2022 to $2.60 billion in 2023 at a c\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/09/2777059/28124/en/Global-Protein-Assays-Market-Report-2023-A-4-2-Billion-Market-by-2027-Long-term-Forecast-to-2032.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7",
            "publishedAt": "2023-11-09T09:58:00Z",
            "content": "Dublin, Nov. 09, 2023 (GLOBE NEWSWIRE) -- The \"Protein Assays Global Market Report 2023\" report has been added to ResearchAndMarkets.com's offering.\r\nThe global protein assays market is expected to g\u2026 [+6261 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "InsightAce Analytic Pvt. LTd.",
            "title": "mRNA Extraction and Purification Market Latest Q4 2023 Updated Report with Forecast to 2031",
            "description": "Companies covered in this report are Qiagen, Thermo Fisher Scientific, Promega Corporation, Agilent Technologies, Inc, Merck Kgaa, Miltenyi Biotec , Biobasic Inc, Takara Bio, Inc, New England Biolabs, Omega Bio-Tek, Inc, Norgen Biotek, Zymo Research, F. Hoffm\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/15/2780722/0/en/mRNA-Extraction-and-Purification-Market-Latest-Q4-2023-Updated-Report-with-Forecast-to-2031.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/0e88e2e9-67b2-4a38-aa13-e33c9d874fc5",
            "publishedAt": "2023-11-15T07:03:00Z",
            "content": "Jersey City, NJ, Nov. 15, 2023 (GLOBE NEWSWIRE) -- InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled \"Global mRNA Extraction and Purification Market\r\n- By\u2026 [+8708 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Transparency Market Research",
            "title": "Research Antibodies and Reagents Market to Reach USD 23 billion, at a 6.6% CAGR by 2033 - Transparency Market Research Inc.",
            "description": "Increasing application of research antibodies and reagents in cancer research for the detection and measurement of specific cancer markers, as well as for developing new targeted therapies to boost the market demand during the forecast period. Increasing appl\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/23/2785305/32656/en/Research-Antibodies-and-Reagents-Market-to-Reach-USD-23-billion-at-a-6-6-CAGR-by-2033-Transparency-Market-Research-Inc.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/27b21b27-620b-4cae-8360-605a9662092b",
            "publishedAt": "2023-11-23T14:30:00Z",
            "content": "Wilmington, Delaware, United States, Nov. 23, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global research antibodies and reagents market is projected to flourish at a CAGR of 6.6\u2026 [+7642 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Rationalstat LLC",
            "title": "Rapid Medical Diagnostics Market: A Detailed Report on Market Size, Growth Drivers, and Key Players, Highlighting the Rapid Trend of Point-of-Care Testing | RationalStat Market Study",
            "description": "The global rapid medical diagnostics market is expected to reach US$ 23.0 billion by 2030, registering a CAGR of more than 3.4%, essentially driven by the growing focus on early detection and reduced healthcare costs The global rapid medical diagnostics marke\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/29/2787513/0/en/Rapid-Medical-Diagnostics-Market-A-Detailed-Report-on-Market-Size-Growth-Drivers-and-Key-Players-Highlighting-the-Rapid-Trend-of-Point-of-Care-Testing-RationalStat-Market-Study.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/ced67b94-5d6b-4532-b365-e1f1f26f8f16",
            "publishedAt": "2023-11-29T08:27:00Z",
            "content": "Wilmington, Delaware, Nov. 29, 2023 (GLOBE NEWSWIRE) -- According to RationalStat\r\ns\r\n recent market report, the Global \r\nRapid Medical Diagnostics\r\n Market\r\n value is estimated at US$ 18.2 billion i\u2026 [+11635 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research and Markets",
            "title": "Troponin I and T Biomarkers Lead the Way in Cardiac Marker Testing Market Dominance, Predicted to Maintain Market Share",
            "description": "Dublin, Nov. 10, 2023 (GLOBE NEWSWIRE) -- The \"Cardiac Marker Testing Market by Biomarker (Troponin, CK-MB, BNP, hs-CRP, Myoglobin), Product (Instrument (Chemiluminescence, ELISA), Reagents & Kits), Disease (MI, CHF, Atherosclerosis), User, ASP & Buying Crite\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/10/2778243/28124/en/Troponin-I-and-T-Biomarkers-Lead-the-Way-in-Cardiac-Marker-Testing-Market-Dominance-Predicted-to-Maintain-Market-Share.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7",
            "publishedAt": "2023-11-10T12:38:00Z",
            "content": "Dublin, Nov. 10, 2023 (GLOBE NEWSWIRE) -- The \"Cardiac Marker Testing Market by Biomarker (Troponin, CK-MB, BNP, hs-CRP, Myoglobin), Product (Instrument (Chemiluminescence, ELISA), Reagents &amp; Kit\u2026 [+6242 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research and Markets",
            "title": "Global Hemoglobin A1C Testing Market Forecast Report to 2028 - Utilizing Data-driven Insights and Innovative Assays for Enhanced Decision-making in Hemoglobin A1C Testing",
            "description": "Dublin, Nov. 23, 2023 (GLOBE NEWSWIRE) -- The \"Global Hemoglobin A1C Testing Market, Forecast to 2028\" report has been added to ResearchAndMarkets.com's offering.",
            "url": "https://www.globenewswire.com/news-release/2023/11/23/2785392/28124/en/Global-Hemoglobin-A1C-Testing-Market-Forecast-Report-to-2028-Utilizing-Data-driven-Insights-and-Innovative-Assays-for-Enhanced-Decision-making-in-Hemoglobin-A1C-Testing.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7",
            "publishedAt": "2023-11-23T17:13:00Z",
            "content": "Dublin, Nov. 23, 2023 (GLOBE NEWSWIRE) -- The \"Global Hemoglobin A1C Testing Market, Forecast to 2028\" report has been added to ResearchAndMarkets.com's offering.\r\nThe global hemoglobin A1C (HbA1c) t\u2026 [+3452 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Future Market Insights Global and Consulting Pvt. Ltd.",
            "title": "CTNG Testing Market Projected to Reach US$ 3.9 Billion by 2033 | Future Market Insights, Inc.",
            "description": "Increasing Prevalence of STD Infections Among Teenagers Driving Advancements in CTNG Testing Procedures. Operational barriers and the high cost of CT/NG testing instruments is likely to hamper the growth of CT/NG testing market Increasing Prevalence of STD In\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/13/2778810/0/en/CTNG-Testing-Market-Projected-to-Reach-US-3-9-Billion-by-2033-Future-Market-Insights-Inc.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/915d2f9c-7dc6-40c7-995c-2ba168208baa",
            "publishedAt": "2023-11-13T10:30:00Z",
            "content": "NEWARK, Del, Nov. 13, 2023 (GLOBE NEWSWIRE) -- The value of the global CTNG testing market is projected to grow from US$ 1.8 billion in 2023 to US$ 3.9 billion by 2033. Between 2023 and 2033, the dem\u2026 [+8476 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Emergen Research",
            "title": "Polymerase chain reaction Market Size Worth USD 19.24 Billion in 2032 | Emergen Research",
            "description": "The Polymerase chain reaction (PCR) market revenue growth can be attributed to rising clinical diagnostic applications, rapid technological advancements and applications in drug development The Polymerase chain reaction (PCR) market revenue growth can be attr\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/21/2784169/0/en/Polymerase-chain-reaction-Market-Size-Worth-USD-19-24-Billion-in-2032-Emergen-Research.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/8825ef83-644c-4c64-a208-863167237797",
            "publishedAt": "2023-11-21T15:00:00Z",
            "content": "Vancouver, Nov. 21, 2023 (GLOBE NEWSWIRE) -- The global polymerase chain reaction (PCR) market\r\n size was USD 8.50 Billion in 2022 and is expected to register a revenue CAGR of 8.5% during the foreca\u2026 [+12306 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Emergen Research",
            "title": "Antimicrobial Susceptibility Testing Market Size Worth USD 6.08 Billion in 2032 | Emergen Research",
            "description": "The growing resistance of microbes to different drugs is one of the significant factors influencing the antibiotic susceptibility testing/ antibiotic sensitivity testing market growth The growing resistance of microbes to different drugs is one of the signifi\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/16/2782056/0/en/Antimicrobial-Susceptibility-Testing-Market-Size-Worth-USD-6-08-Billion-in-2032-Emergen-Research.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/8825ef83-644c-4c64-a208-863167237797",
            "publishedAt": "2023-11-16T16:00:00Z",
            "content": "Vancouver, Nov. 16, 2023 (GLOBE NEWSWIRE) -- The global antimicrobial susceptibility testing market\r\n is projected to be worth USD 6.08 Billion by 2032, according to a current analysis by Emergen Res\u2026 [+8827 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Vantage Market Research",
            "title": "With 14.90% CAGR, Single Cell Analysis Market Size Worth $6.99 Billion by 2030 | Vantage Market Research",
            "description": "WASHINGTON, Nov. 29, 2023 (GLOBE NEWSWIRE) -- The Global Single Cell Analysis Market achieved a valuation of $2.30 Billion in 2022 and is anticipated to exceed $6.99 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 14.90% during the forec\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/29/2787767/0/en/With-14-90-CAGR-Single-Cell-Analysis-Market-Size-Worth-6-99-Billion-by-2030-Vantage-Market-Research.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/b992ad70-52a5-4308-9ec3-ec32ebfecaee",
            "publishedAt": "2023-11-29T13:32:00Z",
            "content": "WASHINGTON, Nov. 29, 2023 (GLOBE NEWSWIRE) -- The Global Single Cell Analysis Market achieved a valuation of $2.30 Billion in 2022 and is anticipated to exceed $6.99 Billion by 2030, reflecting a com\u2026 [+10531 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Emergen Research",
            "title": "Protein Engineering Market Size to Reach USD 11.22 Billion in 2032 | Emergen Research",
            "description": "Increasing demand for protein-based drugs and rising investments by governments for protein engineering are driving the demand of the Protein Engineering market Increasing demand for protein-based drugs and rising investments by governments for protein engine\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/12/04/2790051/0/en/Protein-Engineering-Market-Size-to-Reach-USD-11-22-Billion-in-2032-Emergen-Research.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/8825ef83-644c-4c64-a208-863167237797",
            "publishedAt": "2023-12-04T13:52:00Z",
            "content": "Vancouver, Dec. 04, 2023 (GLOBE NEWSWIRE) -- The global Protein Engineering Market\r\n is expected to reach USD 11.22 Billion by 2032, according to a new report by Emergen Research. The growth of this \u2026 [+8549 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research and Markets",
            "title": "Rapid Expansion of Point-of-Care Testing Propels Lateral Flow Assay Market to $12.10 Billion by 2028",
            "description": "Dublin, Nov. 06, 2023 (GLOBE NEWSWIRE) -- The \"Global Lateral Flow Assay Market: Analysis and Trends by Product Type, Application, Technology, End User and Region with Impact of COVID-19 and Forecast up to 2028\" report has been added to ResearchAndMarkets.com\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/06/2773860/28124/en/Rapid-Expansion-of-Point-of-Care-Testing-Propels-Lateral-Flow-Assay-Market-to-12-10-Billion-by-2028.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7",
            "publishedAt": "2023-11-06T11:13:00Z",
            "content": "Dublin, Nov. 06, 2023 (GLOBE NEWSWIRE) -- The \"Global Lateral Flow Assay Market: Analysis and Trends by Product Type, Application, Technology, End User and Region with Impact of COVID-19 and Forecast\u2026 [+8910 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Polaris Market Research & Consulting LLP",
            "title": "Global Blood Group Typing Market Size Projected to Reach USD 4.56 Billion By 2032, at 7.4% CAGR: Polaris Market Research",
            "description": "As per the recent [115+ Pages] analysis by Polaris Market Research, the global blood group typing market size was valued at USD 2.23 billion in 2022 and is predicted to reach USD 4.56 billion by 2032. Also, the study states that the market reveals a robust 7.\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/23/2785228/0/en/Global-Blood-Group-Typing-Market-Size-Projected-to-Reach-USD-4-56-Billion-By-2032-at-7-4-CAGR-Polaris-Market-Research.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/cf0a808d-3703-43f4-9b34-ec72345f8585",
            "publishedAt": "2023-11-23T12:17:00Z",
            "content": "New York, NY, Nov. 23, 2023 (GLOBE NEWSWIRE) -- Polaris Market Research has published a recent study report titled \"Blood Group Typing Market Share, Size, Trends, Industry Analysis Report, By Test Ty\u2026 [+12872 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "MarketsandMarkets Research Pvt. Ltd.",
            "title": "Digital PCR (dPCR) and Real-time PCR (qPCR) Market is Expected to Reach $12.4 billion | MarketsandMarkets.",
            "description": "Chicago, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Digital PCR (dPCR) and Real-time PCR (qPCR) market in terms of revenue was estimated to be worth $8.5 billion in 2023 and is poised to reach $12.4 billion by 2028, growing at a CAGR of 7.8% from 2023 to 2028 accordin\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/06/2774021/0/en/Digital-PCR-dPCR-and-Real-time-PCR-qPCR-Market-is-Expected-to-Reach-12-4-billion-MarketsandMarkets.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/afcc5182-4ae0-43a8-a965-4351d590b7ed",
            "publishedAt": "2023-11-06T13:00:00Z",
            "content": "Chicago, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Digital PCR (dPCR) and Real-time PCR (qPCR) market in terms of revenue was estimated to be worth $8.5 billion in 2023 and is poised to reach $12.4 billion b\u2026 [+13307 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Emergen Research",
            "title": "Needles Market Size Worth USD 15.27 Billion in 2032 | Emergen Research",
            "description": "Increasing number of hospitals and clinic in emerging countries and rising prevalence of chronic illnesses, such as cancer and diabetes, are key factors driving needles market revenue growth. Increasing number of hospitals and clinic in emerging countries and\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/22/2784705/0/en/Needles-Market-Size-Worth-USD-15-27-Billion-in-2032-Emergen-Research.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/8825ef83-644c-4c64-a208-863167237797",
            "publishedAt": "2023-11-22T12:17:00Z",
            "content": "Vancouver, Nov. 22, 2023 (GLOBE NEWSWIRE) -- The global needles market\r\n size was USD 6.91 Billion in 2022 and is expected to register a rapid revenue CAGR of 8.7% during the forecast period. Key dri\u2026 [+12017 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research and Markets",
            "title": "Neurological Biomarkers Research Report 2023: A Global $18.75 Billion Market by 2030 with Pipeline Analysis of Alzheimer's, Parkinson's, Multiple Sclerosis, & Autism Spectrum Disorder",
            "description": "Dublin, Nov. 14, 2023 (GLOBE NEWSWIRE) -- The \"Neurological Biomarkers Market Size, Share & Trends Analysis Report By Application (Alzheimer's, Parkinson's, Multiple Sclerosis, Autism), By Type, By End-use, By Region, And Segment Forecasts, 2023 - 2030\" repor\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/14/2779816/28124/en/Neurological-Biomarkers-Research-Report-2023-A-Global-18-75-Billion-Market-by-2030-with-Pipeline-Analysis-of-Alzheimer-s-Parkinson-s-Multiple-Sclerosis-Autism-Spectrum-Disorder.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7",
            "publishedAt": "2023-11-14T10:28:00Z",
            "content": "Dublin, Nov. 14, 2023 (GLOBE NEWSWIRE) -- The \"Neurological Biomarkers Market Size, Share &amp; Trends Analysis Report By Application (Alzheimer's, Parkinson's, Multiple Sclerosis, Autism), By Type, \u2026 [+7006 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Coherent Market Insights Pvt. Ltd",
            "title": "Macrophage Markers Market to Reach US$ 398.2 Million, Globally, by 2030 at 6.5% CAGR: Coherent Market Insights",
            "description": "Macrophage Markers refers to a set of molecular signatures used to identify and characterize macrophages, which are a type of white blood cell involved in the immune response. These markers can include surface proteins, enzymes, receptors, and other molecules\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/07/2774955/0/en/Macrophage-Markers-Market-to-Reach-US-398-2-Million-Globally-by-2030-at-6-5-CAGR-Coherent-Market-Insights.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/450ec960-647a-4b12-8885-a4afd6739e88",
            "publishedAt": "2023-11-07T12:18:00Z",
            "content": "Burlingame, Nov. 07, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, global\u00a0macrophage markers market is estimated to be valued at US$ 256.2 million in 2023 and is expected to exhibit\u2026 [+10206 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "DataHorizzon Research",
            "title": "Next Generation Sequencing Market To Reach USD 45.9 Billion By 2032, Says DataHorizzon Research",
            "description": "A Detailed Analysis Report of the Next Generation Sequencing Market. A Detailed Analysis Report of the Next Generation Sequencing Market.",
            "url": "https://www.globenewswire.com/news-release/2023/11/09/2777125/0/en/Next-Generation-Sequencing-Market-To-Reach-USD-45-9-Billion-By-2032-Says-DataHorizzon-Research.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/ee0903f0-279f-4537-8a89-666461d3d324",
            "publishedAt": "2023-11-09T11:30:00Z",
            "content": "Fort Collins, Colorado, Nov. 09, 2023 (GLOBE NEWSWIRE) -- According to DataHorizzon Research, the\u00a0Next Generation Sequencing (NGS) Market size was valued at USD 7.2 Billion in 2022 and is expected to\u2026 [+5673 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research and Markets",
            "title": "Pharmaceutical and Biotechnology Industry Dominates the Life Science Equipment Market in 2023, Fueling Growth in the Sector",
            "description": "Dublin, Nov. 07, 2023 (GLOBE NEWSWIRE) -- The \"Life Science Equipment Market by Technology, End User - Global Forecast to 2030\" report has been added to ResearchAndMarkets.com's offering.",
            "url": "https://www.globenewswire.com/news-release/2023/11/07/2774781/28124/en/Pharmaceutical-and-Biotechnology-Industry-Dominates-the-Life-Science-Equipment-Market-in-2023-Fueling-Growth-in-the-Sector.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7",
            "publishedAt": "2023-11-07T10:08:00Z",
            "content": "Dublin, Nov. 07, 2023 (GLOBE NEWSWIRE) -- The \"Life Science Equipment Market by Technology, End User - Global Forecast to 2030\" report has been added to ResearchAndMarkets.com's offering.\r\nThe global\u2026 [+7833 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research and Markets",
            "title": "Latin America Point Of Care (PoC) Diagnostics (Glucose, Hb1Ac, Fertility, Cardiac Markers, Hematology) Market Analysis Report 2023-2030",
            "description": "Dublin, Nov. 07, 2023 (GLOBE NEWSWIRE) -- The \"Latin America Point Of Care Diagnostics Market Size, Share & Trends Analysis Report By Product (Glucose Testing, Hb1Ac Testing, Fertility, Cardiac Markers, Hematology) By End-use, By Country, And Segment Forecast\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/07/2774841/28124/en/Latin-America-Point-Of-Care-PoC-Diagnostics-Glucose-Hb1Ac-Fertility-Cardiac-Markers-Hematology-Market-Analysis-Report-2023-2030.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7",
            "publishedAt": "2023-11-07T11:18:00Z",
            "content": "Dublin, Nov. 07, 2023 (GLOBE NEWSWIRE) -- The \"Latin America Point Of Care Diagnostics Market Size, Share &amp; Trends Analysis Report By Product (Glucose Testing, Hb1Ac Testing, Fertility, Cardiac M\u2026 [+6639 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research and Markets",
            "title": "Global Hemoglobin A1C (HbA1C) Testing Business Research Report 2023-2030: Rising Popularity of Near Patient Testing Benefits HbA1c Devices Market",
            "description": "Dublin, Dec. 04, 2023 (GLOBE NEWSWIRE) -- The \"Hemoglobin A1C (HbA1C) Testing - Global Strategic Business Report\" report has been added to ResearchAndMarkets.com's offering.Global Hemoglobin A1C (HbA1C) Testing Market to Reach $2.3 Billion by 2030The global m\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/12/04/2790214/28124/en/Global-Hemoglobin-A1C-HbA1C-Testing-Business-Research-Report-2023-2030-Rising-Popularity-of-Near-Patient-Testing-Benefits-HbA1c-Devices-Market.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7",
            "publishedAt": "2023-12-04T16:08:00Z",
            "content": "Dublin, Dec. 04, 2023 (GLOBE NEWSWIRE) -- The \"Hemoglobin A1C (HbA1C) Testing - Global Strategic Business Report\" report has been added to ResearchAndMarkets.com's offering.\r\nGlobal Hemoglobin A1C (H\u2026 [+7605 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Vantage Market Research",
            "title": "Biosensors Market Size & Share to Surpass $45.95 Billion by 2030 | Vantage Market Research",
            "description": "WASHINGTON, Nov. 27, 2023 (GLOBE NEWSWIRE) -- The Biosensors Market is valued at USD 26.75 Billion in 2022 and is expected to reach USD 45.95 Billion by 2030 at a CAGR of 7% over the forecast period 2023-2030.",
            "url": "https://www.globenewswire.com/news-release/2023/11/27/2786146/0/en/Biosensors-Market-Size-Share-to-Surpass-45-95-Billion-by-2030-Vantage-Market-Research.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/b992ad70-52a5-4308-9ec3-ec32ebfecaee",
            "publishedAt": "2023-11-27T13:16:00Z",
            "content": "WASHINGTON, Nov. 27, 2023 (GLOBE NEWSWIRE) -- The Biosensors Market is valued at USD 26.75 Billion in 2022 and is expected to reach USD 45.95 Billion by 2030 at a CAGR of 7% over the forecast period \u2026 [+11297 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Rationalstat LLC",
            "title": "Sexually Transmitted Diseases Testing Market Size Anticipated to Reach US$ 14.2 Billion by 2030, Driven by Growing Prevalence of STDs and Rising Awareness | According to RationalStat",
            "description": "The global sexually transmitted diseases testing market is projected to reach US$ 14.2 billion by 2030, at a CAGR of 7.6%. The global sexually transmitted diseases testing market is projected to reach US$ 14.2 billion by 2030, at a CAGR of 7.6%.",
            "url": "https://www.globenewswire.com/news-release/2023/11/14/2779713/0/en/Sexually-Transmitted-Diseases-Testing-Market-Size-Anticipated-to-Reach-US-14-2-Billion-by-2030-Driven-by-Growing-Prevalence-of-STDs-and-Rising-Awareness-According-to-RationalStat.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/ced67b94-5d6b-4532-b365-e1f1f26f8f16",
            "publishedAt": "2023-11-14T07:00:00Z",
            "content": "Wilmington, Delaware, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Global Sexually Transmitted Diseases Testing Market size is valued at US$ 8.5 billion in 2023 and is predicted to rise at a substantial CAGR of\u2026 [+11606 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Rationalstat LLC",
            "title": "New Market Report | Microfluidics Market Size, Share, Competition Analysis, Segmental Share, and Forecasts, 2023-2030 | According to RationalStat",
            "description": "The global microfluidics market is projected to reach US$ 101.5 billion by 2030, at a CAGR of 23.2%. Microfluidics market is driven by the diversity of the medical diagnostic market. The global microfluidics market is projected to reach US$ 101.5 billion by 2\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/09/2776973/0/en/New-Market-Report-Microfluidics-Market-Size-Share-Competition-Analysis-Segmental-Share-and-Forecasts-2023-2030-According-to-RationalStat.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/ced67b94-5d6b-4532-b365-e1f1f26f8f16",
            "publishedAt": "2023-11-09T07:00:00Z",
            "content": "Wilmington, Delaware, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Global \r\nMicrofluidics \r\nMarket\r\n size is valued at US$ 23.6 billion in 2023 and is predicted to rise at a substantial CAGR of 23.2% during the\u2026 [+10561 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": null,
            "title": "Activist investor Ubben shutting down Inclusive Capital -WSJ",
            "description": "(marketscreener.com) Jeff Ubben, one of Wall\nStreet's most prominent activist investors, is shutting down\nInclusive Capital Partners, a new firm designed to focus on\nsocial investing, three years after starting it.\n The Wall Street Journal reported on Wednesd\u2026",
            "url": "https://www.marketscreener.com/quote/stock/INCAP-OYJ-1412466/news/Activist-investor-Ubben-shutting-down-Inclusive-Capital-WSJ-45465851/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdblanc.png",
            "publishedAt": "2023-11-29T21:00:14Z",
            "content": "NEW YORK, Nov 29 (Reuters) - Jeff Ubben, one of Wall\r\nStreet's most prominent activist investors, is shutting down\r\nInclusive Capital Partners, a new firm designed to focus on\r\nsocial investing, thre\u2026 [+3014 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Investing.com"
            },
            "author": "Reuters",
            "title": "Activist investor Ubben shutting down Inclusive Capital -WSJ",
            "description": "Activist investor Ubben shutting down Inclusive Capital -WSJ",
            "url": "https://www.investing.com/news/economy/activist-investor-ubben-shutting-down-inclusive-capital-wsj-3246180",
            "urlToImage": "https://i-invdn-com.investing.com/news/LYNXNPEC4G0Z5_L.jpg",
            "publishedAt": "2023-11-29T21:16:19Z",
            "content": "By Svea Herbst-Bayliss\r\nNEW YORK (Reuters) - Jeff Ubben, one of Wall Street's most prominent activist investors, is shutting down Inclusive Capital Partners, a new firm designed to focus on social in\u2026 [+2951 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research and Markets",
            "title": "The Drug Abuse Testing Industry 2024-2030: Urine-based Tests Dominate the Landscape, with China Emerging as a Key Player",
            "description": "Dublin, Nov. 06, 2023 (GLOBE NEWSWIRE) -- The \"Drug Abuse Testing Market, Size, Global Forecast 2024-2030, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis\" report has been added to ResearchAndMarkets.com's offering.",
            "url": "https://www.globenewswire.com/news-release/2023/11/06/2773889/28124/en/The-Drug-Abuse-Testing-Industry-2024-2030-Urine-based-Tests-Dominate-the-Landscape-with-China-Emerging-as-a-Key-Player.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7",
            "publishedAt": "2023-11-06T11:38:00Z",
            "content": "Dublin, Nov. 06, 2023 (GLOBE NEWSWIRE) -- The \"Drug Abuse Testing Market, Size, Global Forecast 2024-2030, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis\" \u2026 [+5043 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "The Insight Partners",
            "title": "Infectious Disease Diagnostics Market Size (Product, Technology) - Reach $59.95 Billion by 2030 at 5.7% CAGR with Veterinary Segment Driving Growth During 2022 to 2030 | The Insight Partners",
            "description": "North America is the largest contributor for infectious disease diagnostics market growth during 2022 to 2030. North America is the largest contributor for infectious disease diagnostics market growth during 2022 to 2030.",
            "url": "https://www.globenewswire.com/news-release/2023/11/08/2775823/0/en/Infectious-Disease-Diagnostics-Market-Size-Product-Technology-Reach-59-95-Billion-by-2030-at-5-7-CAGR-with-Veterinary-Segment-Driving-Growth-During-2022-to-2030-The-Insight-Partner.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/efd8c9da-ac10-487a-a083-ec8f33cad35e",
            "publishedAt": "2023-11-08T07:04:00Z",
            "content": "Pune, India, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Infectious diseases are generated by microorganisms such as fungi, viruses, bacteria, and other organism species. Infectious disease diagnostics are the\u2026 [+7779 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "MarketsandMarkets Research Pvt. Ltd.",
            "title": "Nucleic Acid Isolation and Purification Market is Expected to Reach $9.4 billion | MarketsandMarkets.",
            "description": "Chicago, Nov. 10, 2023 (GLOBE NEWSWIRE) -- Nucleic Acid Isolation and Purification market in terms of revenue was estimated to be worth $6.4 billion in 2023 and is poised to reach $9.4 billion by 2028, growing at a CAGR of 8.1% from 2023 to 2028 according to \u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/10/2778231/0/en/Nucleic-Acid-Isolation-and-Purification-Market-is-Expected-to-Reach-9-4-billion-MarketsandMarkets.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/afcc5182-4ae0-43a8-a965-4351d590b7ed",
            "publishedAt": "2023-11-10T12:30:00Z",
            "content": "Chicago, Nov. 10, 2023 (GLOBE NEWSWIRE) -- Nucleic Acid Isolation and Purification market in terms of revenue was estimated to be worth $6.4 billion in 2023 and is poised to reach $9.4 billion by 202\u2026 [+11483 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "The Insight Partners",
            "title": "Image Analysis Software Market Growth to Hit 9.9% CAGR, Globally, by 2028 - Exclusive Report by The Insight Partners",
            "description": "The global image analysis software market share worth $7.67 billion by 2028, at a growing CAGR of 9.9% from 2021 to 2028. The global image analysis software market share worth $7.67 billion by 2028, at a growing CAGR of 9.9% from 2021 to 2028.",
            "url": "https://www.globenewswire.com/news-release/2023/11/07/2775260/0/en/Image-Analysis-Software-Market-Growth-to-Hit-9-9-CAGR-Globally-by-2028-Exclusive-Report-by-The-Insight-Partners.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/efd8c9da-ac10-487a-a083-ec8f33cad35e",
            "publishedAt": "2023-11-07T14:33:00Z",
            "content": "Pune, India, Nov. 07, 2023 (GLOBE NEWSWIRE) -- According to a new report on Image Analysis Software Market Size and Forecast (20212028), Global and Regional Share, Trends, and Growth Opportunity Anal\u2026 [+7394 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Allied Analytics LLP",
            "title": "Proteomics Market Is Expected to Generate USD 98.1 Billion by 2031: Claims Allied Market Research",
            "description": "The global proteomics market is expanding rapidly due to factors such as surge in occurrence of cancer and chronic disease, discoveries of biomarkers, clinical diagnostics for treatment of diseases and diagnosis, rising focus on product use in drug developmen\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/17/2782471/0/en/Proteomics-Market-Is-Expected-to-Generate-USD-98-1-Billion-by-2031-Claims-Allied-Market-Research.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/9c430095-89f7-48b4-b8f0-e1f4ed1a5660",
            "publishedAt": "2023-11-17T11:10:00Z",
            "content": "Wilmington, Delaware, Nov. 17, 2023 (GLOBE NEWSWIRE) -- As per the recent report published by Allied Market Research, the global proteomics market size is expected to gain $98.1 billion by 2031. The \u2026 [+8164 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research and Markets",
            "title": "United States $480+ Mn Hydroxyapatite Markets, Competition, Forecast & Opportunities, 2028F",
            "description": "Dublin, Nov. 24, 2023 (GLOBE NEWSWIRE) -- The \"United States Hydroxyapatite Market, Competition, Forecast & Opportunities, 2018-2028\" report has been added to ResearchAndMarkets.com's offering.United States Hydroxyapatite Market has valued at USD391.03 millio\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/24/2785637/28124/en/United-States-480-Mn-Hydroxyapatite-Markets-Competition-Forecast-Opportunities-2028F.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7",
            "publishedAt": "2023-11-24T15:03:00Z",
            "content": "Dublin, Nov. 24, 2023 (GLOBE NEWSWIRE) -- The \"United States Hydroxyapatite Market, Competition, Forecast &amp; Opportunities, 2018-2028\" report has been added to ResearchAndMarkets.com's offering.\r\n\u2026 [+7504 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Vantage Market Research",
            "title": "Flow Cytometry Market Size & Share to Surpass $9.03 Billion by 2030 | Vantage Market Research",
            "description": "WASHINGTON, Nov. 20, 2023 (GLOBE NEWSWIRE) -- According to Vantage Market Research, the Global Flow Cytometry Market is estimated to be valued at USD 9.03 Billion by 2030 at an exponential growth of 8.8% in the next seven years.",
            "url": "https://www.globenewswire.com/news-release/2023/11/20/2783009/0/en/Flow-Cytometry-Market-Size-Share-to-Surpass-9-03-Billion-by-2030-Vantage-Market-Research.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/b992ad70-52a5-4308-9ec3-ec32ebfecaee",
            "publishedAt": "2023-11-20T09:54:00Z",
            "content": "WASHINGTON, Nov. 20, 2023 (GLOBE NEWSWIRE) -- According to Vantage Market Research, the Global Flow Cytometry Market is estimated to be valued at USD 9.03 Billion by 2030 at an exponential growth of \u2026 [+15151 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "PR Newswire UK"
            },
            "author": null,
            "title": "Gastric Cancer Diagnostic Market to Reach $3.8 Billion, Globally, by 2032 at 5.3% CAGR: Allied Market Research",
            "description": "Rise in incidence of gastric cancer, advancements in diagnostic technologies, surge in awareness about gastric cancer drive the growth of the global gastric cancer diagnostic market.\u202f PORTLAND, Ore., Nov. 10, 2023 /PRNewswire/ -- Allied Market Research publis\u2026",
            "url": "https://www.prnewswire.co.uk/news-releases/gastric-cancer-diagnostic-market-to-reach-3-8-billion-globally-by-2032-at-5-3-cagr-allied-market-research-301984674.html",
            "urlToImage": "https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg?p=facebook",
            "publishedAt": "2023-11-10T15:20:00Z",
            "content": "Rise in incidence of gastric cancer, advancements in diagnostic technologies, surge in awareness about gastric cancer drive the growth of the global gastric cancer diagnostic market.\u00a0\r\nPORTLAND, Ore.\u2026 [+9496 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Coherent Market Insights Pvt. Ltd",
            "title": "Bioinformatics Market to Surpass $83.9 Billion by 2030: Coherent Market Insights",
            "description": "Bioinformatics is an interdisciplinary field that develops methods and software tools for understanding biological data, in particular when annotating genomes and interpreting biological meaning. It is used for biological experiments and computations to deter\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/28/2787108/0/en/Bioinformatics-Market-to-Surpass-83-9-Billion-by-2030-Coherent-Market-Insights.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/450ec960-647a-4b12-8885-a4afd6739e88",
            "publishedAt": "2023-11-28T14:45:00Z",
            "content": "Burlingame, Nov. 28, 2023 (GLOBE NEWSWIRE) -- According to\u00a0Coherent Market Insights, The global bioinformatics market was valued at US$ 22.1 Billion in 2023 and is forecast to reach a value of US$ 83\u2026 [+11452 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research and Markets",
            "title": "Global Gene Expression Research Report 2023: A $20.94 Billion Market by 2030 - High Investment in Genomic Research and Increased Focus on Precision Medicine",
            "description": "Dublin, Nov. 28, 2023 (GLOBE NEWSWIRE) -- The \"Gene Expression Market Size, Share & Trends Analysis Report By Product (DNA Chip/Microarray, Kits & Reagents), By Technique (Promoter Analysis, RNA Exp.), By Capacity, By Process, By Application, And Segment Fore\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/28/2787072/28124/en/Global-Gene-Expression-Research-Report-2023-A-20-94-Billion-Market-by-2030-High-Investment-in-Genomic-Research-and-Increased-Focus-on-Precision-Medicine.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7",
            "publishedAt": "2023-11-28T14:13:00Z",
            "content": "Dublin, Nov. 28, 2023 (GLOBE NEWSWIRE) -- The \"Gene Expression Market Size, Share &amp; Trends Analysis Report By Product (DNA Chip/Microarray, Kits &amp; Reagents), By Technique (Promoter Analysis, \u2026 [+6881 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research and Markets",
            "title": "World Blood Testing Market Trends Analysis Report 2022 & 2023-2030: Focus on Glucose, Lipid, COVID-19, A1C, CRP, Vitamin D, ALT, AST, Thyroid Stimulating Hormone, PSA, & Cortisol Testing",
            "description": "Dublin, Nov. 14, 2023 (GLOBE NEWSWIRE) -- The \"Blood Testing Market Size, Share & Trends Analysis Report By Test Type (Glucose, Lipid, COVID-19, A1C, CRP, Vitamin D, ALT, AST, Thyroid Stimulating Hormone, PSA, Cortisol), By Region, And Segment Forecasts, 2023\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/14/2779738/28124/en/World-Blood-Testing-Market-Trends-Analysis-Report-2022-2023-2030-Focus-on-Glucose-Lipid-COVID-19-A1C-CRP-Vitamin-D-ALT-AST-Thyroid-Stimulating-Hormone-PSA-Cortisol-Testing.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7",
            "publishedAt": "2023-11-14T07:48:00Z",
            "content": "Dublin, Nov. 14, 2023 (GLOBE NEWSWIRE) -- The \"Blood Testing Market Size, Share &amp; Trends Analysis Report By Test Type (Glucose, Lipid, COVID-19, A1C, CRP, Vitamin D, ALT, AST, Thyroid Stimulating\u2026 [+5750 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Vantage Market Research",
            "title": "With 15.60% CAGR, Microfluidics Market Size Worth $66.38 Billion by 2030 | Vantage Market Research",
            "description": "WASHINGTON, Nov. 28, 2023 (GLOBE NEWSWIRE) -- The Global Microfluidics Market achieved a valuation of $20.81 Billion in 2022 and is anticipated to exceed $66.38 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 15.60% during the forecast p\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/28/2787140/0/en/With-15-60-CAGR-Microfluidics-Market-Size-Worth-66-38-Billion-by-2030-Vantage-Market-Research.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/b992ad70-52a5-4308-9ec3-ec32ebfecaee",
            "publishedAt": "2023-11-28T15:03:00Z",
            "content": "WASHINGTON, Nov. 28, 2023 (GLOBE NEWSWIRE) -- The Global Microfluidics Market achieved a valuation of $20.81 Billion in 2022 and is anticipated to exceed $66.38 Billion by 2030, reflecting a compound\u2026 [+11290 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "PIONEERING MARKETDIGITS CONSULTING AND ADVISORY PRIVATE LIMITED",
            "title": "Microfluidics Market estimated to reach USD 21,931 Million by 2030, growing at a CAGR of 10.8% during the forecast period of 2023-2030 - claims MarketDigits in its recent study.",
            "description": "The Global Microfluidics Market was valued USD 6,351.9 Million in 2022 and projected to reach USD 21,931 Million by 2030, growing at a CAGR of 10.8% during the forecast period of 2023-2030. The Global Microfluidics Market was valued USD 6,351.9 Million in 202\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/15/2780851/0/en/Microfluidics-Market-estimated-to-reach-USD-21-931-Million-by-2030-growing-at-a-CAGR-of-10-8-during-the-forecast-period-of-2023-2030-claims-MarketDigits-in-its-recent-study.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/2960b872-d623-4363-9973-e881f17bf42f",
            "publishedAt": "2023-11-15T11:30:00Z",
            "content": "Richmond, Nov. 15, 2023 (GLOBE NEWSWIRE) -- According to a research report \"Microfluidics Market\r\n, by Material (Polymer, Glass, Silicon, Metal, Ceramics), Application (Point of care testing, Clinica\u2026 [+10570 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "PIONEERING MARKETDIGITS CONSULTING AND ADVISORY PRIVATE LIMITED",
            "title": "Food Safety Testing Market projected to reach USD 38.3 Billion by 2030, growing at a CAGR of 7.8% during the forecast period of 2023-2030 a comprehensive study by MarketDigits.",
            "description": "The Global Food Safety Testing Market was valued USD 21.0 Billion in 2023 and projected to reach USD 38.3 Billion by 2030, growing at a CAGR of 7.8% during the forecast period of 2023-2030. The Global Food Safety Testing Market was valued USD 21.0 Billion in \u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/10/2778377/0/en/Food-Safety-Testing-Market-projected-to-reach-USD-38-3-Billion-by-2030-growing-at-a-CAGR-of-7-8-during-the-forecast-period-of-2023-2030-a-comprehensive-study-by-MarketDigits.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/2960b872-d623-4363-9973-e881f17bf42f",
            "publishedAt": "2023-11-10T14:30:00Z",
            "content": "Richmond, Nov. 10, 2023 (GLOBE NEWSWIRE) -- According to a research report \"Food Safety Testing Market\r\n, by Test Type (Allergen Testing, Pathogens {E.coli, Salmonella, Campylobacter, Listeria and Ot\u2026 [+11289 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research and Markets",
            "title": "Digital Polymerase Chain Reaction (PCR) Technology Global Markets Report 2023: Market Revenue Data from 2020 to 2022, Estimates for 2023, forecasts for 2024, and CAGR Projections through 2028",
            "description": "Dublin, Nov. 10, 2023 (GLOBE NEWSWIRE) -- The \"Digital Polymerase Chain Reaction (PCR) Technology: Global Markets\" report has been added to ResearchAndMarkets.com's offering.",
            "url": "https://www.globenewswire.com/news-release/2023/11/10/2778150/28124/en/Digital-Polymerase-Chain-Reaction-PCR-Technology-Global-Markets-Report-2023-Market-Revenue-Data-from-2020-to-2022-Estimates-for-2023-forecasts-for-2024-and-CAGR-Projections-through.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7",
            "publishedAt": "2023-11-10T10:48:00Z",
            "content": "Dublin, Nov. 10, 2023 (GLOBE NEWSWIRE) -- The \"Digital Polymerase Chain Reaction (PCR) Technology: Global Markets\" report has been added to ResearchAndMarkets.com's offering.\r\nThe global dPCR technol\u2026 [+8287 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Future Market Insights Global and Consulting Pvt. Ltd.",
            "title": "Hydroxyapatite Market Grow at a Robust 7.8% CAGR with Projected US$ 1,063.5 million Valuation in 2033 Driven by Expanding Demand in Dental Care and Orthopedics | Future Market Insights, Inc.",
            "description": "As per FMI\u2019s latest analysis, the United States is projected to continue to dominate the North American hydroxyapatite market during the forecast period, owing to the better healthcare infrastructure, the surge in the number of non-invasive cosmetic surgeries\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/22/2784876/0/en/Hydroxyapatite-Market-Grow-at-a-Robust-7-8-CAGR-with-Projected-US-1-063-5-million-Valuation-in-2033-Driven-by-Expanding-Demand-in-Dental-Care-and-Orthopedics-Future-Market-Insights.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/915d2f9c-7dc6-40c7-995c-2ba168208baa",
            "publishedAt": "2023-11-22T15:00:00Z",
            "content": "NEWARK, Del, Nov. 22, 2023 (GLOBE NEWSWIRE) -- The hydroxyapatite market is forecast to expand at 7.8% CAGR over the estimated period, as per FMIs analysis. The industrys size is predicted to reach a\u2026 [+7869 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "The Insight Partners",
            "title": "Microcarriers Market to Hit 12.5% CAGR, Globally, by 2030 - Exclusive Report by The Insight Partners",
            "description": "The global microcarriers market revenue to reach USD 4.17 billion during 2022-2030. The global microcarriers market revenue to reach USD 4.17 billion during 2022-2030.",
            "url": "https://www.globenewswire.com/news-release/2023/11/08/2775826/0/en/Microcarriers-Market-to-Hit-12-5-CAGR-Globally-by-2030-Exclusive-Report-by-The-Insight-Partners.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/efd8c9da-ac10-487a-a083-ec8f33cad35e",
            "publishedAt": "2023-11-08T07:13:00Z",
            "content": "Pune, India, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Microcarriers provide an efficient way to analyze biological data collected from different cell types. This data can be used to discover new drugs and t\u2026 [+7468 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "PIONEERING MARKETDIGITS CONSULTING AND ADVISORY PRIVATE LIMITED",
            "title": "Cell Lysis and Disruption Market projected to reach USD 9.4 Billion by 2030, growing at a CAGR of 8.8% during the forecast period of 2023-2030 - pronounced by MarketDigits in its recent study.",
            "description": "The Global Cell Lysis and Disruption Market was valued USD 4.8 Billion in 2022 and projected to reach USD 9.4 Billion by 2030, growing at a CAGR of 8.8% during the forecast period of 2023-2030. The Global Cell Lysis and Disruption Market was valued USD 4.8 Bi\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/22/2784810/0/en/Cell-Lysis-and-Disruption-Market-projected-to-reach-USD-9-4-Billion-by-2030-growing-at-a-CAGR-of-8-8-during-the-forecast-period-of-2023-2030-pronounced-by-MarketDigits-in-its-recen.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/2960b872-d623-4363-9973-e881f17bf42f",
            "publishedAt": "2023-11-22T13:40:00Z",
            "content": "Richmond, Nov. 22, 2023 (GLOBE NEWSWIRE) -- According to a research report \"Cell Lysis and Disruption Market\r\n, by Technique (Reagent-Based (Detergent, Enzymatic), Physical Disruption (Mechanical Hom\u2026 [+11532 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Precedence Research",
            "title": "Biotechnology Instruments Market Size to Garner Around USD 119.32 Billion by 2032",
            "description": "The global biotechnology instruments market size is estimated to garner around USD 119.32 billion by 2032 and is growing at a CAGR of 4 percent from 2023 to 2032. The global biotechnology instruments market size is estimated to garner around USD 119.32 billio\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/29/2787885/0/en/Biotechnology-Instruments-Market-Size-to-Garner-Around-USD-119-32-Billion-by-2032.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/501140d4-82c8-4a65-82a7-8466b5188635",
            "publishedAt": "2023-11-29T15:00:00Z",
            "content": "Ottawa, Nov. 29, 2023 (GLOBE NEWSWIRE) -- The global biotechnology instruments market size was valued at USD 81 billion in 2022, and grew to USD 83.84 billion in 2023, According to Precedence Researc\u2026 [+15219 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Plos.org"
            },
            "author": "Maya Shofa, Akatsuki Saito",
            "title": "Generation of porcine PK-15 cells lacking the Ifnar1 or Stat2 gene to optimize the efficiency of viral isolation",
            "description": "Because pigs are intermediate or amplifying hosts for several zoonotic viruses, the pig-derived PK-15 cell line is an indispensable tool for studying viral pathogenicity and developing treatments, vaccines, and preventive measures to mitigate the risk of dise\u2026",
            "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0289863",
            "urlToImage": "https://journals.plos.org/plosone/article/figure/image?id=10.1371/journal.pone.0289863.g005&size=inline",
            "publishedAt": "2023-11-08T14:00:00Z",
            "content": "Citation: Shofa M, Saito A (2023) Generation of porcine PK-15 cells lacking the Ifnar1 or Stat2 gene to optimize the efficiency of viral isolation. PLoS ONE 18(11):\r\n e0289863.\r\nhttps://doi.org/10.13\u2026 [+30976 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Plos.org"
            },
            "author": "Tamara Somborac, G\u00fcleycan Lutfullahoglu Bal, Kaneez Fatima, Helena Vihinen, Anja Paatero, Eija Jokitalo, Ville O. Paavilainen, Svetlana Konovalova",
            "title": "The subset of peroxisomal tail-anchored proteins do not reach peroxisomes via ER, instead mitochondria can be involved",
            "description": "Peroxisomes are membrane-enclosed organelles with important roles in fatty acid breakdown, bile acid synthesis and biosynthesis of sterols and ether lipids. Defects in peroxisomes result in severe genetic diseases, such as Zellweger syndrome and neonatal adre\u2026",
            "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0295047",
            "urlToImage": "https://journals.plos.org/plosone/article/figure/image?id=10.1371/journal.pone.0295047.g004&size=inline",
            "publishedAt": "2023-12-01T14:00:00Z",
            "content": "Citation: Somborac T, Lutfullahoglu Bal G, Fatima K, Vihinen H, Paatero A, Jokitalo E, et al. (2023) The subset of peroxisomal tail-anchored proteins do not reach peroxisomes via ER, instead mitochon\u2026 [+38471 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Plos.org"
            },
            "author": "Robyn D. Kokemuller, S. Jo Moore, Jifeng Bian, M. Heather West Greenlee, Justin J. Greenlee",
            "title": "Disease phenotype of classical sheep scrapie is changed upon experimental passage through white-tailed deer",
            "description": "Author summary Passage of the sheep-derived US No. 13\u20137 classical scrapie isolate through white-tailed deer results in a change in disease phenotype that is observed when the deer-passaged scrapie agent is inoculated back into sheep or ovinized mice. Upon pas\u2026",
            "url": "https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1011815",
            "urlToImage": "https://journals.plos.org/plospathogens/article/figure/image?id=10.1371/journal.ppat.1011815.g009&size=inline",
            "publishedAt": "2023-12-04T14:00:00Z",
            "content": "Citation: Kokemuller RD, Moore SJ, Bian J, West Greenlee MH, Greenlee JJ (2023) Disease phenotype of classical sheep scrapie is changed upon experimental passage through white-tailed deer. PLoS Patho\u2026 [+49106 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Plos.org"
            },
            "author": "Meng Bian, Shan Li, Hanzong Zhou, Lijun Bi, Yong Shen, Chen Tingjin, Xinbing Yu, Yan Huang, Qingxia Xu",
            "title": "ASPSCR-1 and Sirt-5 alleviate Clonorchis liver fluke rCs NOSIP-induced oxidative stress, proliferation, and migration in cholangiocarcinoma cells",
            "description": "Author summary Clonorchis sinensis (C. sinensis) is prevalent in China, Korea, and Vietnam, and 15\u201320 million people are estimated to be infected by this fluke, creating a socio-economic burden in epidemic regions. It is generally believed that excretory-secr\u2026",
            "url": "https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0011727",
            "urlToImage": "https://journals.plos.org/plosntds/article/figure/image?id=10.1371/journal.pntd.0011727.g005&size=inline",
            "publishedAt": "2023-11-10T14:00:00Z",
            "content": "Citation: Bian M, Li S, Zhou H, Bi L, Shen Y, Tingjin C, et al. (2023) ASPSCR-1 and Sirt-5 alleviate Clonorchis liver fluke rCs NOSIP-induced oxidative stress, proliferation, and migration in cholang\u2026 [+29170 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Plos.org"
            },
            "author": "Sukanya G. Gakare, Jay M. Bhatt, Kishore Kumar S. Narasimhan, Shashank M. Dravid",
            "title": "Glutamate delta-1 receptor regulates oligodendrocyte progenitor cell differentiation and myelination in normal and demyelinating conditions",
            "description": "In this study, we investigated the role of glutamate delta 1 receptor (GluD1) in oligodendrocyte progenitor cell (OPC)-mediated myelination during basal (development) and pathophysiological (cuprizone-induced demyelination) conditions. Initially, we sought to\u2026",
            "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0294583",
            "urlToImage": "https://journals.plos.org/plosone/article/figure/image?id=10.1371/journal.pone.0294583.g005&size=inline",
            "publishedAt": "2023-11-20T14:00:00Z",
            "content": "Animals\r\nWildtype (WT) and GluD1 KO male and female mice were used. GluD1 KO mice were obtained from Dr. Jian Zuo [48]. All procedures were approved by the Creighton University Institutional Animal C\u2026 [+8122 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Plos.org"
            },
            "author": "Jifeng Zhu, Lina Zhang, Zechao Xue, Zil\u00fce Li, Chun Wang, Fanyan Chen, Yalin Li, Yang Dai, Yonghua Zhou, Sha Zhou, Xiaojun Chen, Kuniko Okumura-Noji, Rui Lu, Shinji Yokoyama, Chuan Su",
            "title": "Vaccination against the HDL receptor of S. japonicum inhibits egg embryonation and prevents fatal hepatic complication in rabbit model",
            "description": "Author summary Schistosomiasis remains a major neglected tropical disease affecting over 200 million people worldwide. Human and animals infected with Schistosoma japonicum (S. japonicum) or Schistosoma mansoni develop a severe liver pathology which arises wh\u2026",
            "url": "https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0011749",
            "urlToImage": "https://journals.plos.org/plosntds/article/figure/image?id=10.1371/journal.pntd.0011749.g007&size=inline",
            "publishedAt": "2023-11-29T14:00:00Z",
            "content": "Citation: Zhu J, Zhang L, Xue Z, Li Z, Wang C, Chen F, et al. (2023) Vaccination against the HDL receptor of S. japonicum inhibits egg embryonation and prevents fatal hepatic complication in rabbit m\u2026 [+38478 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Plos.org"
            },
            "author": "Shota Moriya, Hiromi Kazama, Hirotsugu Hino, Naoharu Takano, Masaki Hiramoto, Shin Aizawa, Keisuke Miyazawa",
            "title": "Clarithromycin overcomes stromal cell-mediated drug resistance against proteasome inhibitors in myeloma cells via autophagy flux blockage leading to high NOXA expression",
            "description": "We previously reported that macrolide antibiotics, such as clarithromycin (CAM), blocked autophagy flux, and simultaneous proteasome and autophagy inhibition by bortezomib (BTZ) plus CAM resulted in enhanced apoptosis induction in multiple myeloma (MM) cells \u2026",
            "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0295273",
            "urlToImage": "https://journals.plos.org/plosone/article/figure/image?id=10.1371/journal.pone.0295273.g007&size=inline",
            "publishedAt": "2023-12-01T14:00:00Z",
            "content": "Abstract\r\nWe previously reported that macrolide antibiotics, such as clarithromycin (CAM), blocked autophagy flux, and simultaneous proteasome and autophagy inhibition by bortezomib (BTZ) plus CAM re\u2026 [+56979 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Plos.org"
            },
            "author": "Han Chen, Ming F. Lye, Christoph Gorgulla, Scott B. Ficarro, Gregory D. Cuny, David A. Scott, Fan Wu, Paul W. Rothlauf, Xiaoou Wang, Rosio Fernandez, Jean M. Pesola, Sorin Draga, Jarrod A. Marto, James M. Hogle, Haribabu Arthanari, Donald M. Coen",
            "title": "A small molecule exerts selective antiviral activity by targeting the human cytomegalovirus nuclear egress complex",
            "description": "Author summary Human cytomegalovirus (HCMV) causes severe diseases in newborns and in adults with compromised immunity. With no available vaccine for this virus, and with the drawbacks of existing anti-HCMV drugs, there is a pressing need for new effective tr\u2026",
            "url": "https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1011781",
            "urlToImage": "https://journals.plos.org/plospathogens/article/figure/image?id=10.1371/journal.ppat.1011781.g007&size=inline",
            "publishedAt": "2023-11-17T14:00:00Z",
            "content": "Citation: Chen H, Lye MF, Gorgulla C, Ficarro SB, Cuny GD, Scott DA, et al. (2023) A small molecule exerts selective antiviral activity by targeting the human cytomegalovirus nuclear egress complex. \u2026 [+85227 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Plos.org"
            },
            "author": "Padmapriya Sekar, Sumati Rajagopalan, Estela Shabani, Usheer Kanjee, Marc A. Schureck, Gunjan Arora, Mary E. Peterson, Boubacar Traore, Peter D. Crompton, Manoj T. Duraisingh, Sanjay A. Desai, Eric O. Long",
            "title": "NK cell-induced damage to P.falciparum-infected erythrocytes requires ligand-specific recognition and releases parasitophorous vacuoles that are phagocytosed by monocytes in the presence of immune IgG",
            "description": "Author summary The parasite Plasmodium falciparum is the main contributor to malaria disease that causes more than 600,000 deaths/year, primarily among young children. To control disease, it is critical to understand how clinical immunity develops in people e\u2026",
            "url": "https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1011585",
            "urlToImage": "https://journals.plos.org/plospathogens/article/figure/image?id=10.1371/journal.ppat.1011585.g008&size=inline",
            "publishedAt": "2023-11-08T14:00:00Z",
            "content": "Citation: Sekar P, Rajagopalan S, Shabani E, Kanjee U, Schureck MA, Arora G, et al. (2023) NK cell-induced damage to P.falciparum-infected erythrocytes requires ligand-specific recognition and releas\u2026 [+78217 chars]"
        }
    ]
}